You are here

  • Home
  • Archive
  • Volume 30, Issue 2
  • Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19

Article metrics

Article menu
Download PDFPDF
Short report
Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19

 

Online download statistics by month:

Online download statistics by month: April 2021 to April 2025

AbstractFullPdf
Apr 202185084788
May 202123222435
Jun 2021777715
Jul 2021787019
Aug 2021575623
Sep 2021393714
Oct 2021615729
Nov 20219910031
Dec 20211331338
Jan 202217317313
Feb 202213213210
Mar 20222212198
Apr 20221251257
May 202211111220
Jun 2022898511
Jul 202289897
Aug 202211111015
Sep 20221061068
Oct 202290895
Nov 202280816
Dec 2022959212
Jan 2023989812
Feb 202315515513
Mar 202324324742
Apr 2023793307
May 202316732
Jun 20237701
Jul 20239613
Aug 202311701
Sep 20233201
Oct 20237800
Nov 202313821
Dec 20238702
Jan 20245710
Feb 20249030
Mar 20242631521
Apr 202410411
May 20249115
Jun 20248802
Jul 20245000
Aug 20247101
Sep 202411901
Oct 20247811
Nov 20246111
Dec 20243222
Jan 20257610
Feb 20252600
Mar 2025610
Apr 2025600
Total63473577504